Ginger--an herbal medicinal product with broad anti-inflammatory actions
- PMID: 16117603
- DOI: 10.1089/jmf.2005.8.125
Ginger--an herbal medicinal product with broad anti-inflammatory actions
Abstract
The anti-inflammatory properties of ginger have been known and valued for centuries. During the past 25 years, many laboratories have provided scientific support for the long-held belief that ginger contains constituents with antiinflammatory properties. The original discovery of ginger's inhibitory effects on prostaglandin biosynthesis in the early 1970s has been repeatedly confirmed. This discovery identified ginger as an herbal medicinal product that shares pharmacological properties with non-steroidal anti-inflammatory drugs. Ginger suppresses prostaglandin synthesis through inhibition of cyclooxygenase-1 and cyclooxygenase-2. An important extension of this early work was the observation that ginger also suppresses leukotriene biosynthesis by inhibiting 5-lipoxygenase. This pharmacological property distinguishes ginger from nonsteroidal anti-inflammatory drugs. This discovery preceded the observation that dual inhibitors of cyclooxygenase and 5-lipoxygenase may have a better therapeutic profile and have fewer side effects than non-steroidal anti-inflammatory drugs. The characterization of the pharmacological properties of ginger entered a new phase with the discovery that a ginger extract (EV.EXT.77) derived from Zingiber officinale (family Zingiberaceae) and Alpina galanga (family Zingiberaceae) inhibits the induction of several genes involved in the inflammatory response. These include genes encoding cytokines, chemokines, and the inducible enzyme cyclooxygenase-2. This discovery provided the first evidence that ginger modulates biochemical pathways activated in chronic inflammation. Identification of the molecular targets of individual ginger constituents provides an opportunity to optimize and standardize ginger products with respect to their effects on specific biomarkers of inflammation. Such preparations will be useful for studies in experimental animals and humans.
Similar articles
-
Zingiber officinale var. rubrum: Red Ginger's Medicinal Uses.Molecules. 2022 Jan 25;27(3):775. doi: 10.3390/molecules27030775. Molecules. 2022. PMID: 35164040 Free PMC article. Review.
-
Zingiber Officinale Roscoe: The Antiarthritic Potential of a Popular Spice-Preclinical and Clinical Evidence.Nutrients. 2024 Mar 5;16(5):741. doi: 10.3390/nu16050741. Nutrients. 2024. PMID: 38474869 Free PMC article. Review.
-
The hidden mechanism beyond ginger (Zingiber officinale Rosc.) potent in vivo and in vitro anti-inflammatory activity.J Ethnopharmacol. 2018 Mar 25;214:113-123. doi: 10.1016/j.jep.2017.12.019. Epub 2017 Dec 16. J Ethnopharmacol. 2018. PMID: 29253614
-
Ginger (Zingiber officinale) and rheumatic disorders.Med Hypotheses. 1989 May;29(1):25-8. doi: 10.1016/0306-9877(89)90162-x. Med Hypotheses. 1989. PMID: 2501634
-
Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research.Food Chem Toxicol. 2008 Feb;46(2):409-20. doi: 10.1016/j.fct.2007.09.085. Epub 2007 Sep 18. Food Chem Toxicol. 2008. PMID: 17950516 Review.
Cited by
-
Antioxidative properties, phenolic compounds, and in vitro protective efficacy of multi-herbal hydro-alcoholic extracts of ginger, turmeric, and thyme against the toxicity of aflatoxin B1 on mouse macrophage RAW264.7 cell line.Food Sci Nutr. 2024 Aug 20;12(10):8013-8029. doi: 10.1002/fsn3.4257. eCollection 2024 Oct. Food Sci Nutr. 2024. PMID: 39479629 Free PMC article.
-
Preventing social defeat stress-induced behavioural and neurochemical alterations by repeated treatment with a mix of Centella asiatica, Echinacea purpurea and Zingiber officinale standardized extracts.Front Pharmacol. 2024 Aug 26;15:1439811. doi: 10.3389/fphar.2024.1439811. eCollection 2024. Front Pharmacol. 2024. PMID: 39253374 Free PMC article.
-
Reversal of high-fat diet-induced cognitive impairment and oxidative stress in the brain through Zingiber officinale supplementation.Metab Brain Dis. 2024 Dec;39(8):1495-1503. doi: 10.1007/s11011-024-01406-8. Epub 2024 Aug 9. Metab Brain Dis. 2024. PMID: 39120852
-
6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway.PLoS One. 2024 Jul 15;19(7):e0305358. doi: 10.1371/journal.pone.0305358. eCollection 2024. PLoS One. 2024. PMID: 39008492 Free PMC article.
-
Potential of Natural Products as Therapeutic Agents for Inflammatory Diseases.Antiinflamm Antiallergy Agents Med Chem. 2024;23(3):149-163. doi: 10.2174/0118715230307969240614102321. Antiinflamm Antiallergy Agents Med Chem. 2024. PMID: 38984571 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous